Financials data is unavailable for this security.
View more
Year on year Procter & Gamble Health Ltd 's revenues fell -6.37% from 12.30bn to 11.51bn. has fallen -12.42% from 2.29bn to 2.01bn.
| Gross margin | 71.42% |
|---|---|
| Net profit margin | 18.77% |
| Operating margin | 24.53% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Procter & Gamble Health Ltd fell by 1.97bn. However, the company earned 2.28bn from its operations for a Cash Flow Margin of 19.83%. In addition the company used 68.70m on investing activities and also paid 4.18bn in financing cash flows.
| Cash flow per share | 147.18 |
|---|---|
| Price/Cash flow per share | 37.12 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in dividends per share increased 15.79% while earnings per share excluding extraordinary items fell by -12.42%. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 83.86% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -5.98 |
More ▼
